Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well bortezomib works in treating patients with stage
IIIB or stage IV lung cancer. Bortezomib may stop the growth of tumor cells by blocking some
of the enzymes needed for cell growth.